pH Pharma   Report issue

For profit Phase 1 Phase 3
Founded: Seoul Korea, Republic of (2015)

Organization Overview

First Clinical Trial
2017
NCT03106532
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

pH Pharma | pH Pharma Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

Sovesudil (3 trials)

Drugs in Phase 1 Trials (1)

php-303 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 2)

Low Tension Glaucoma (Phase 2)

Overweight (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2